Umicore Catalysis Symposium - Uniting Innovators in San Francisco

Leading Industry Experts Converge for Insights and Collaboration

Umicore PMC hosted its second Umicore Catalysis Symposium in San Francisco, CA, drawing about 50 scientists from leading Bay Area pharmaceutical companies like Genentech and Gilead, among others. The event featured a lineup of technical presentations by esteemed experts.

Prof. Neufeldt, Montana State University: Promising advancements in achieving cross-coupling at less reactive C-X bonds in heteroarenes.

James Murray, Amgen: Sotorasib® development utilizing Reaction Progress Kinetic Analysis.

Kyle Mack, Genentech: Optimization of enantioselective cross-coupling via machine learning.

Haifeng Yang, Merck & Co, Inc.: New catalytic methods for late-stage tritiation of sp3 C-H bonds.

Achim Link, Solvias: Efficient asymmetric hydrogenation at an industrial scale through catalyst screening and optimization.

Joshua Dunetz, Gilead: Sonogashira carbonylation in synthesizing their early-phase development drug candidate.

Prof. Rovis, Columbia University: The development of Os-based catalysts enabling low-energy excitation photoredox catalysis.

Philip Wheeler, Umicore: The importance of metal catalysis in sustainable chemical processes and the value of planning metal separation and recycling steps in process development.